These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30392846)

  • 1. The imbalance of peripheral interleukin-18 and transforming growth factor-β1 levels in patients with cirrhosis and esophageal varices.
    Swidnicka-Siergiejko A; Wereszczynska-Siemiatkowska U; Siemiatkowski A; Wasielica-Berger J; Janica J; Mroczko B; Dabrowski A
    Cytokine; 2019 Jan; 113():440-445. PubMed ID: 30392846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin 1 and transforming growth factor-β1 correlate with liver function and portal pressure in cirrhotic patients.
    Wereszczynka-Siemiatkowska U; Swidnicka-Siergiejko A; Siemiatkowski A; Bondyra Z; Wasielica-Berger J; Mroczko B; Janica J; Dabrowski A
    Cytokine; 2015 Dec; 76(2):144-151. PubMed ID: 26144293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic analysis of esophageal varices in patients with liver cirrhosis using color Doppler ultrasound.
    Li FH; Hao J; Xia JG; Li HL; Fang H
    World J Gastroenterol; 2005 Aug; 11(29):4560-5. PubMed ID: 16052688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis C virus-related liver cirrhosis.
    Zaghloul SG; Wahab EA; Seleem WM; Hanafy AS; Gomaa AF; Lakouz K; Amin AI
    Drug Discov Ther; 2019; 13(2):108-113. PubMed ID: 31080201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TGF beta 1 and ET-1 expression in the peripheral blood of patients with cirrhosis].
    Yang L; Liu X; Fu H; Qiang O; Huang M
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):202-3, 212. PubMed ID: 12600085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.
    Ming D; Yu X; Guo R; Deng Y; Li J; Lin C; Su M; Lin Z; Su Z
    Viral Immunol; 2015 May; 28(4):209-16. PubMed ID: 25710085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
    Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
    Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-invasive assessment of portal hypertension in patients with liver cirrhosis using FibroScan transient elastography].
    Liu F; Li TH; Han T; Xiang HL; Zhang HS
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):840-4. PubMed ID: 24331694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive liver fibrosis markers: use of serum levels of cytokines IL 1α and TGF ß1 in management of chronic liver diseases.
    Mehmedović A; Mesihović R; Prnjavorac B; Vanis N; Vukobrat-Bijedić Z; Borovac N; Zubčević N; Pilav A; Gornjaković S; Kulo-Ćesić A; Mujarić E; Saray A
    Med Glas (Zenica); 2013 Feb; 10(1):20-7. PubMed ID: 23348156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of Doppler ultrasound of the portal system with endoscopic changes caused by portal hypertension in cirrhotic patients].
    de Bem RS; Lora FL; de Souza RC; Trippia MA; Amarante HM; Carmes ER
    Arq Gastroenterol; 2006; 43(3):178-83. PubMed ID: 17160231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Non-Invasive Markers as Predictor of Esophageal Varices in Liver Cirrhosis.
    Khadka D; Prajapati S; Sudhamshu KC; Shrestha JK; Karki N; Jaishi B; Regmi K; Khadka S
    JNMA J Nepal Med Assoc; 2017; 56(208):412-6. PubMed ID: 29453471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.
    Giannitrapani L; Granà W; Licata A; Schiavone C; Montalto G; Soresi M
    Med Princ Pract; 2018; 27(5):466-471. PubMed ID: 30107378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of interleukin 17 and transforming growth factor-beta 1 in hepatitis C patients with disease progression.
    Elbanan WK; Fathy SA; Ibrahim RA; Hegazy MGA
    Trop Biomed; 2020 Dec; 37(4):1093-1104. PubMed ID: 33612761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
    Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
    Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive assessment of portal hypertension in patients with alcoholic cirrhosis.
    Alempijevic T; Sokic-Milutinovic A; Milicic B; Jesic R; Balovic A; Popovic D; Krstic M
    Turk J Gastroenterol; 2012 Jun; 23(3):239-46. PubMed ID: 22798113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.
    Eslam M; Ampuero J; Jover M; Abd-Elhalim H; Rincon D; Shatat M; Camacho I; Kamal A; Lo Iacono O; Nasr Z; Grande L; Banares R; Khattab MA; Romero-Gomez M
    Ann Hepatol; 2013; 12(4):588-98. PubMed ID: 23813137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
    Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
    J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
    Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
    Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analysis of β-blockers for the primary prevention of liver cirrhosis with clinically significant portal hypertension with no or small esophageal varices].
    Su X; Li WJ; Chen Z; Wu QB; Yin MH; Han X; Zhang DP; Zhou XQ; Zhu H
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1237-1245. PubMed ID: 36891704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenergic beta blockade in liver cirrhosis with portal hypertension? Doppler ultrasound measurement of the short-term effect of propranolol on the portal system].
    Wruck U; Wermke W
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):371-5. PubMed ID: 1615718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.